Cardiac
POC testing is a heart-related diagnostic test, which is carried out
at or near the point-of-care of a patient. POC testing is a blood
diagnostic test involved in detection of cholesterol and blood
coagulation. This diagnosis helps physicians to examine the risk of
developing thrombosis and extreme bleeding inside blood vessel, which
leads to cardiac arrest. Moreover, cardiac POC includes troponin and
brain natriuretic peptide analysis test to identify cardiovascular
disorders such as coronary artery disease, myocardial infarction, and
heart failure. Cardiac POC test significantly lowers time consumed in
extracting data/reports. In most cases, diagnosis reports are
provided within an hour after the submission of test samples. Thus,
cardiac POC tests help reduce turnaround time noticeably, allowing
instant patient response and effective management of cardiac
diseases.
According
to the World Health Organization (WHO) 2016, one-third of ischemic
heart disease cases are observed due to high cholesterol levels.
Increase in cholesterol and blood coagulants in blood arteries, are
estimated to cause cardiac disorders. For instance, according to WHO,
2016, over 2.5 million deaths and around 29 million individuals were
recorded to be suffering from cardiac disorders. The cardiac POC
testing device provides easy-to-use system with the correct
assessment of cholesterol levels and heart ailments.
Get
Exclusive Sample Copy of This Report @
https://www.coherentmarketinsights.com/insight/request-sample/192
The
global cardiac POC testing market is estimated to be valued at US$
2,104.1 million in 2017 and is expected to witness a CAGR of 7.1 %
during the forecast period (2017 – 2025).
Market
Dynamics
The
market for cardiac POC testing devices is gaining significant
traction due to rising prevalence of cardiac disorders. According to
World Health Organizations (WHO), 2011, around 8 million people
suffered from coronary and peripheral heart diseases, which recorded
the major cause of all the deaths, accounting for around 44% of total
deaths in the U.S. Technological innovations and developments of
cardiac POC testing devices are contributing to the market growth.
For instance, the FDA approval of Firmware software in August 2017,
launched by Abbott Laboratories is embedded in the hardware of a
cardiac testing device. With this device, the cardiac rhythm can be
easily monitored as well as control for the people at high-risk.
However, lack of operating knowledge and economic instability in
emerging economies are the factors restraining the market growth.
Increasing
prevalence of cardiac disorders significantly drives growth of the
cardiac POC testing devices market
According
to the FH Foundation, a patient-centered organization devoted to
research and education of Familial Hypercholesterolemia (FH), 2015, 1
in 200-500 people suffered from familial hypercholesterolemia
worldwide. With increasing population, this number expected to
increase in the future, thereby leading to growth in demand for
testing cholesterol levels in individuals. This in turn, is expected
to propel the overall growth of the cardiac POC testing devices
market. According to the World Health Organization 2013, around 33.5
million of the global population was estimated to have suffered from
coronary artery disease, a major condition leading to heart attack.
The growing prevalence of cardiovascular ailments is expected to
increase the demand for cardiac POC testing devices, in turn, driving
growth of the market.
Competitive
Landscape
Key
companies covered as a part of this study include Abbott
Laboratories, Siemens Healthineers, BG Medicine Inc., Roche
Diagnostics, Nexus-Dx, LifeSign LLC., and Medtronic Inc.
Detailed
Segmentation:
Global
Cardiac POC Testing Device Market, By Product Type:
Cardiac
Markers Test
-
Cardiac Troponin (cTn) Test
-
Myoglobin Test
-
Creatine Kinase MB Isoenzyme (CK-MB) Test
-
Combinational Test Kits
-
Brain Natriuretic Peptide (BNP) Test
Analyzers
Browse
Complete Research Report @
https://www.coherentmarketinsights.com/market-insight/cardiac-poc-testing-devices-market-192
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment